European funding and consortium development
Quint Healthcare helps companies, hospitals, universities and research institutes develop fundable European health and medical-technology projects. The work covers funding strategy, proposal development, consortium design, evaluator-informed review and selected post-award leadership.
Why this matters now
Europe is using public policy and funding to improve the translation of science into application. The Commission's life-sciences strategy includes support for multi-country trials, faster market access and innovation procurement, while acknowledging that Europe is losing ground to other regions in converting research strength into real-world solutions.
This makes public funding strategically important, particularly where clinical validation is necessary before private capital or procurement can engage. It also favours proposals in which medical need, technical development, evidence, adoption and exploitation are connected from the outset.
When this service is useful
- A strong scientific project needs a funding route and application sequence.
- A Horizon Europe or national call appears relevant, but the fit is uncertain.
- A consortium must be built around clear work packages, responsibilities and clinical value.
- Previous proposals received respectable scores without reaching the funding threshold.
- A clinical department has strong research but limited proposal capacity.
- A company needs non-dilutive funding for evidence generation or translational development.
- A funded consortium needs medical, scientific or cross-partner project leadership.
Funding strategy before proposal writing
The first decision is not how to write the application. It is whether the project, programme, call, consortium role, readiness and timing fit.
A funding strategy considers:
- the scientific and medical objective;
- technology and evidence maturity;
- the required partners and infrastructure;
- programme priorities and expected impact;
- the applicant's role, budget and long-term exploitation path;
- which preparation must be completed before the call opens.
The European Commission publishes Horizon Europe health priorities and work programmes through Cluster 1: Health and the Funding & Tenders Portal.
What we do
Funding landscape and project fit
We assess which European, German or selected regional instruments are credible for the project and which are not. The result is a prioritised funding route with readiness gaps and decision points.
Consortium architecture
We help define:
- the clinical and scientific objective;
- partner roles and selection criteria;
- work packages, tasks, milestones and deliverables;
- dependencies across clinical, technical and exploitation work;
- governance and decision-making;
- a proportionate budget structure.
Proposal development
Scope can include overall narrative, medical and scientific sections, impact, implementation, exploitation, dissemination, work packages and coordination of partner input. The writing remains anchored to the scoring criteria and the call text.
Evaluator-informed review
Dr Karl Quint has served as an expert evaluator for a European Commission executive agency since 2019 and as a mentor or evaluator in other innovation programmes. Reviews therefore examine not only scientific quality, but also whether the proposal makes excellence, impact and implementation easy to assess.
Post-award medical and project leadership
For selected projects, Quint Healthcare can lead medical or scientific work packages, coordinate cross-disciplinary partners, manage milestones and help maintain alignment between clinical need, technical development and validation.
Relevant experience
Documented experience includes:
- co-development of a successful multi-million-euro Horizon Europe proposal for artificial-placenta research with more than ten partners across Europe and North America;
- participation in a multi-year BMBF consortium on non-invasive monitoring in premature infants;
- European project work in digital interventions for chronic kidney disease;
- grant development for medical devices, digital health and biopharmaceutical innovation;
- successful national, European and international funding applications;
- evaluation and mentoring across healthcare innovation networks.
Figures and outcomes are used only where they are supported by the supplied CV and project material. They should be refreshed when a public case study is prepared.
Deliverables
- funding landscape and route recommendation;
- call-fit and readiness assessment;
- consortium map and partner brief;
- work-package and governance structure;
- full or partial proposal development;
- proposal review against the scoring criteria;
- interview or hearing preparation where applicable;
- medical or scientific work-package leadership after award.
Boundaries
No consultant can guarantee a funding decision. Quint Healthcare does not recommend forcing a project into a poorly matched call and generally works on a defined fee rather than a pure success-fee basis. Legal, financial and formal grant-management specialists are integrated when needed.
A practical starting point
Proposal review or funding-fit assessment
For an existing draft, we review the proposal against the call and scoring logic, identify where an evaluator cannot verify the claimed strength and recommend the highest-value revisions.
For an earlier project, we assess programme fit, consortium needs, readiness and timing before substantial writing begins.
